Richard Barry
CIK 1562371 · President & CEO · last filed 2026-10-01
Richard Barry is a President & CEO who has filed 40 SEC Form 4 insider transactions across 6 companies since 2012. The most recent filing shows the insider bought $278.1K of FLNA on Oct 1, 2026. Across all open-market trades the lifetime net is −$7.4M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $65.1M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
SRPT price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
SAN RAFAEL, CA 94901
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| FLNA | President & CEO | 1,337,964 | $0.49 | $654.1K | $356.3K | 2 | 2026-10-01 |
| SRPT | Director | 2,993,542 | $17.78 | $53.23M | -$12.11M | 23 | 2026-06-05 |
| CASSAVA SCIENCES INC (SAVA) Delisted | President & CEO | 938,060 | $2.34 | $2.20M | $4.63M | 11 | 2025-11-24 |
| CASSAVA SCIENCES INC (SAVAW) Delisted | Director | 469,562 | $0.03 | $14.1K | $0 | 1 | 2024-04-25 |
| MDXG | Director | 3,338,135 | $3.37 | $11.23M | $0 | 1 | 2020-08-06 |
| MABVAX THERAPEUTICS HOLDINGS, INC. (TELK) Delisted | 10%+ Owner | 30,475 | — | — | -$300.5K | 2 | 2012-12-19 |
Recent Filings
40 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-10-01 | FLNA | Buy (P) | +306,813 | $278.1K | EDGAR |
| 2026-09-30 | FLNA | Buy (P) | +93,091 | $78.2K | EDGAR |
| 2026-06-05 | SRPT | Grant (A) | +16,875 | $0 | EDGAR |
| 2025-11-24 | CASSAVA SCIENCES INC (SAVA) Delisted | Buy (P) | +150,000 | $414.0K | EDGAR |
| 2025-11-20 | CASSAVA SCIENCES INC (SAVA) Delisted | Buy (P) | +73,385 | $201.8K | EDGAR |
| 2025-09-23 | CASSAVA SCIENCES INC (SAVA) Delisted | Buy (P) | +7,172 | $16.4K | EDGAR |
| 2025-09-22 | CASSAVA SCIENCES INC (SAVA) Delisted | Buy (P) | +237,941 | $534.7K | EDGAR |
| 2025-05-19 | SRPT | Exer (M) | +12,350 | $403.0K | EDGAR |
| 2025-05-15 | SRPT | Exer (M) | +20,246 | $389.4K | EDGAR |
| 2025-04-21 | CASSAVA SCIENCES INC (SAVA) Delisted | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.